September 14, 2011
Predicting Treatments For Hepatitis C
(Ivanhoe Newswire) — Genotyping hepatitis C patients significantly improves doctors´ ability to predict whether or not patients will respond to antiviral treatment.
The results of the study suggest that an interaction between IL28B, HLA-C and KIRs genes provides a mechanism for hepatitis C viral control and highlight new insights into how the drug combination of pegylated interferon alpha and ribavirin clears hepatitis C virus infections, findings that may lead to improved therapies in the future. The findings have yet to be confirmed in patients of non-European descent.